Changes in Other Comprehensive Income

12 Months Ended

Dec. 31, 2024

Other Comprehensive Income (Loss), Net of Tax, Period Change [Abstract]

NOTE O – CHANGES IN OTHER COMPREHENSIVE INCOME

The following table provides the reclassifications out of Other comprehensive income, net of tax attributable to Boston Scientific common stockholders:


(in millions)	Foreign Currency Translation Adjustments		Net Change in Derivative Financial Instruments		Net Change in Defined Benefit Pensions and Other Items		Total
Balance as of December 31, 2023	$	(96)	$	154	$	(8)	$	49
Other comprehensive income (loss) before reclassifications	246		142		(9)		379
(Income) loss amounts reclassified from accumulated other comprehensive income	(14)		(141)		1		(154)
Total other comprehensive income (loss)	232		1		(8)		225
Balance as of December 31, 2024	$	136	$	155	$	(16)	$	275


(in millions)	Foreign Currency Translation Adjustments		Net Change in Derivative Financial Instruments		Net Change in Defined Benefit Pensions and Other Items		Total
Balance as of December 31, 2022	$	(1)	$	269	$	1	$	269
Other comprehensive income (loss) before reclassifications	(87)		63		(10)		(34)
(Income) loss amounts reclassified from accumulated other comprehensive income	(8)		(178)		1		(185)
Total other comprehensive income (loss)	(95)		(115)		(9)		(219)
Balance as of December 31, 2023	$	(96)	$	154	$	(8)	$	49

Refer to Note D – Hedging Activities and Fair Value Measurements for further detail on our net investment hedges recorded in Foreign currency translation adjustment and our cash flow hedges recorded in Net change in derivative financial instruments.

The gains and losses on defined benefit and pension items before reclassifications and gains and losses on defined benefit and pension items reclassified from Accumulated other comprehensive income (loss), net of tax were reduced by income tax impacts of approximately $3 million in 2024 and approximately $5 million in 2023.